India in talks to buy 50 million doses of Pfizer vaccine - WSJ

India is in talks to buy 50 million doses of Pfizer Inc and German partner BioNTech SE's COVID-19 vaccine, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

A Pfizer spokesperson said it was in talks with the government to supply vaccines, but declined to provide further details. The Indian health ministry did not immediately respond to Reuters request for comment. To be sure, the drugmaker has not yet sought permission for use of its vaccine in India.